Abstract
ABSTRACTGlycation of recombinant human interferon-gamma (rhIFN-γ) causes conformational alterations of the molecule and results in reduction of its biologic activity. The aim of this study was to find adequate approaches for prevention of glycation in order to obtain a stable recombinant protein with sustained biologic activity. To this end we investigated the effect of seven chemical compounds (acetylsalicylic acid, vitamin B1, aminoguanidine, arginine, pyridoxine, pyridoxal 5′-phosphate and pyridoxamine) on the biologic activity of rhIFN-γ produced in Escherichia coli. The obtained results showed that rhIFN-γ isolated from bacterial cells grown in the presence of 0.1 mM acetylsalicylic acid was the least affected by glycation. It demonstrated high stability in solution and biologic activity of about 2×106 IU/mg over three months of storage at -20°C.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
